Exosens reported first‑quarter revenue of EUR 122.6 million, representing a 19.7% increase compared with the same period last year overall.
The Detection and Imaging division generated EUR 34.6 million in revenue, up 44.5% year‑over‑year during the quarter, reflecting strong demand.
Adjusted gross margin rose to EUR 63.5 million, a 20.1% increase over the prior year for the reporting period, underscoring improved profitability.
Exosens reaffirmed its 2026 guidance and expects capacity expansion benefits in Europe and United States to begin in the second half of 2026.